HTGM

HTG Molecular Diagnostics, Inc. Common Stock
HTGM

Overview Fund Activity
Delisted

HTGM was delisted on the 14th of June, 2023.

Back to rankings

22 hedge funds and large institutions have $3.19M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
1
Armistice Capital
New York
$1.16M
2
Millennium Management
2
Millennium Management
New York
$38K
3
Morgan Stanley
3
Morgan Stanley
New York
$21K
4
Citigroup
4
Citigroup
New York
$4K
5
UBS Group
5
UBS Group
Switzerland
$6K

Top Sellers

1
ACM
1
AIGH Capital Management
Maryland
$0
2
WVP
2
Worth Venture Partners
New Jersey
$0
3
CPA
3
Cowen Prime Advisors
New York
$462K
4
SC
4
Samjo Capital
New York
$563K
5
NCM
5
Nantahala Capital Management
Connecticut
$397K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
Wells Fargo
27
Wells Fargo
California
$0 41 +1 +3%
1832 Asset Management
28
1832 Asset Management
Ontario, Canada
$0 66 +66 New
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$0 337 +310 +1,148%
1
2